Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target.
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Improved Sleep in Military Personnel is Associated with Changes in the Expression of Inflammatory Genes and Improvement in Depression SymptomsPalliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study.The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients.Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy aloneMethod to Assess Interactivity of Drugs with Nonparallel Concentration-Effect Relationships.Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy.Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines
P2860
Q26746104-CB52E560-741D-4C34-BE10-6D83F94EFBB4Q28262070-1B0073DC-4B18-4771-9B84-B676FE757235Q35948096-1518D2F4-2324-41B3-B27B-C42CA67BAF78Q36545229-50A96C32-5C60-4F9E-9111-C69AFD71AF5FQ37742267-D8B33BEF-D97F-42BD-90A0-98C80C0DAFF7Q38866872-A99523F1-5585-4E15-A35F-1651F80D777AQ40236553-C340C5D9-FB17-4E37-BAAA-39D13787A91AQ41695046-00B86B4A-874E-4ABC-97ED-933201DA5981Q49176545-694DBC1A-7127-43C9-A460-E98ABA4C9E72Q49787797-0126F339-2C89-46CF-8816-B57B85AD68D1Q53817619-5EF4BF90-83ED-4AF2-958D-EB317BC6E2F0Q58776042-5DA3AF8B-D5C5-413B-98CD-B55FBBD4811B
P2860
Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sequential combination of deci ...... ng Wnt pathway nuclear target.
@ast
Sequential combination of deci ...... ng Wnt pathway nuclear target.
@en
type
label
Sequential combination of deci ...... ng Wnt pathway nuclear target.
@ast
Sequential combination of deci ...... ng Wnt pathway nuclear target.
@en
prefLabel
Sequential combination of deci ...... ng Wnt pathway nuclear target.
@ast
Sequential combination of deci ...... ng Wnt pathway nuclear target.
@en
P2093
P2860
P356
P1476
Sequential combination of deci ...... ng Wnt pathway nuclear target.
@en
P2093
Hongyan Tong
Juan Carlos Vera
Kongfei Li
Zhengping Zhuang
Zhigang Ren
P2860
P2888
P356
10.1186/1479-5876-12-167
P577
2014-06-12T00:00:00Z
P5875
P6179
1009272561